PPA News

Chattem Announces Court States Intention to Approve Final PPA Settlement
Chattem, Inc., a leading marketer and manufacturer of branded consumer products, announced today that a fairness hearing to consider final approval of the class action settlement which the Company previously reached in the phenylpropanolamine (PPA) litigation related to the Company's Dexatrim(R) brand was held in the United States District Court for the Western District of Washington before Judge Barbara J. Rothstein on August 26, 2004.
source: Businesswire.com - 08-27-2004

How drug makers sought to keep popular cold and diet remedies on store shelves after their own study linked them to strokes.
Tracy Patton had just arrived at a community theater rehearsal in August 2000 when she felt such a searing explosion in the back of her head that it knocked her to her knees.
source: LA Times- 03-28-2004

Dexatrim on trial in Florida.
Lawsuit claims former Dexatrim ingredient may be connected to Cape Coral woman's stroke.
source: Bonitanews.com - 03-25-2004

Philly gets relief from Alka Seltzer suits
PHILADELPHIA - A Philadelphia judge has begun tossing out lawsuits by people including an Arizonan who said they suffered strokes after taking Alka-Seltzer Plus Cold medicine saying...
source: Tuscon Citizen Local News - 10-02-2003

PPA Lawsuits Updates: PPA Lawsuits Increasing
Drug manufacturers responsible for over-the-counter medications containing PPA are preparing for the onset of lawsuits related to the Food & Drug Administration's recent announcement that PPA is linked to hemorrhagic strokes. The nation's leading drug manufacturers, including such companies as American Home Products Corp., Bayer Corp., Bristol-Myers Squibb Co., Novartis Corp., ...
source: InjuryBoard.com - 05-24-2001

Results of FDA-mandated study gauging risk of stroke with PPA
FDA asked the pharmaceutical industry to conduct a study that evaluated the risk of hemorrhagic stroke from taking phenylpropanolamine. The drug was allowed to be marketed while this study was being done based on the previous recommendations of the expert panels.
source: FDA.gov

Transcript of FDA Committee meeting reviewing safety issues of PPA in over-the-counter drugs
On October 19, 2000 an FDA advisory committee issued a warning about an ingredient contained in many popular over-the-counter and prescription cold and weight loss medicines. The committee said that phenylpropanolamine, also known as PPA, may be responsible for hundreds of strokes in otherwise healthy peopleÉ under the age of...
source: FDA.gov